Dambkowski Carl
Chief Medical Officer
Dambkowski Carl has filed 18 SEC Form 4 filings (51 transaction rows) across 2 companies, including APGE, ORKA, with disclosures dating back to 2025. 16 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Dambkowski Carl is listed as Chief Medical Officer at Apogee Therapeutics, Inc. Inside the rolling window, Dambkowski Carl reported no open-market purchases and 14 open-market sales totaling $18.6M in APGE and ORKA. The largest disclosed transaction in the window is a sale of 105,000 ORKA shares on May 21, 2026, worth $6.2M.
Companies traded
Other insiders at APGE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$18.6M
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| APGE | Chief Medical Officer | Sale | 5,500 | $738K | Aug 8 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $730K | Jul 2 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 26,400 | $3.5M | Jun 25 | SEC ↗ | |
| ORKA | Director | Sale | 22,417 | $1.6M | Jun 12 | SEC ↗ | |
| ORKA | Director | Sale | 12,583 | $882K | Jun 12 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $433K | Jun 6 | SEC ↗ | |
| ORKA | Director | Sale | 105,000 | $6.2M | May 22 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $463K | May 8 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $467K | Apr 3 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $391K | Mar 6 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 5,500 | $362K | Feb 4 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 18,700 | $1.5M | Jan 9 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 10,900 | $818K | Dec 5 | SEC ↗ | |
| APGE | Chief Medical Officer | Sale | 10,785 | $594K | Nov 7 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Dambkowski Carl made?
Dambkowski Carl has filed 18 SEC Form 4 filings (51 transaction rows) across 2 companies, including APGE, ORKA since 2025.
Which companies does Dambkowski Carl trade?
Dambkowski Carl has filed SEC Form 4 disclosures for 2 companies, including APGE, ORKA.
When was Dambkowski Carl's most recent SEC Form 4 filing?
Dambkowski Carl's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Dambkowski Carl's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dambkowski Carl is listed as Chief Medical Officer.
What is Dambkowski Carl's total buy and sell value in the current window?
Inside the rolling retention window, Dambkowski Carl bought $0 and sold $18.6M based on SEC Form 4 filings.
What was Dambkowski Carl's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 105,000 ORKA shares on 2026-05-21, worth $6.2M, per SEC Form 4 filings.